Technology News and Research

RSS

Idera second quarter net loss increases to $6.3 million

Idera Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-Like receptors (TLRs).

5 Aug 2011

Acusis agrees to purchase SPi medical transcription business

Acusis, LLC, a leader in medical transcription solutions, announces that it has agreed to purchase the medical transcription assets of SPi America LLC/SPi Technologies, Inc. (SPi), a global business process outsourcing company with headquarters in the Philippines.

5 Aug 2011

Scientists confirm feasibility of new battery-powered skin patch drug delivery system

Scientists have confirmed the feasibility of using a new drug delivery system - the basis for a battery-powered skin patch - to administer medication that shows promise for treating peripheral artery disease (PAD) and healing stubborn skin ulcers and burns.

5 Aug 2011

Clinical warning system that uses wireless sensors can track vital signs of at-risk patients

A clinical warning system that uses wireless sensors to track the vital signs of at-risk patients is undergoing a feasibility study at Barnes-Jewish Hospital in St. Louis.

5 Aug 2011

More Australian women indulging in binge drinking: Study

According to Queensland psychologist and researcher Dr Gavan Palk Australian women are indulging in alcohol consumption and drunken violence more and more these days. One in five young Australian women taking part in a Queensland University of Technology (QUT) study has been involved in alcohol-induced aggression, which is at a similar rate to men.

5 Aug 2011

Insulin pumps and other medical devices ‘hackable’

A diabetic security researcher has identified flaws that could allow an attacker to remotely control insulin pumps and alter the readouts of blood-sugar monitors. As a result, diabetics could get too much or too little insulin, a hormone they need for proper metabolism.

5 Aug 2011

World RNA Interference market will be worth $4 billion by 2017: New report

By 2017, the world RNA Interference market will be worth $4 billion, according to a new report available from companiesandmarkets.com.

5 Aug 2011

Stem cells could provide sperm for infertile males

Researchers have been successful in creating sperm-producing germ cells from stem cells in a lab and transferred them into infertile mice, which after the treatment were able to produce healthy offspring. This new development could help thousands of infertile men become fathers if the method proves similarly effective in humans.

5 Aug 2011

Sirona third quarter revenue increases 34.1% to $244.7 million

Sirona, the dental technology leader, today announced its financial results for the quarter ended June 30, 2011.

5 Aug 2011

MEDSEEK, NextGen enter agreement to create Enterprise Patient Portal

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced it has entered into an agreement with MEDSEEK to create the NextGen Enterprise Patient Portal.

5 Aug 2011

Desalination could help combat worldwide fresh water shortages

Over one-third of the world's population already lives in areas struggling to keep up with the demand for fresh water. By 2025, that number will nearly double.

5 Aug 2011

University of Kentucky pioneers new use of artificial-lung technology

Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial-lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang.

5 Aug 2011

Lantibiotic could prevent harmful bacteria in foods

University of Minnesota researchers have discovered and received a patent for a naturally occurring lantibiotic - a peptide produced by a harmless bacteria - that could be added to food to kill harmful bacteria like salmonella, E. coli and listeria.

5 Aug 2011

Scientists convert human skin cells into forebrain neurons

Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.

5 Aug 2011

Levels of body chemical PCT influence duration of antibiotic use

Measuring the levels of a natural body chemical may allow doctors to reduce the duration of antibiotic use and improve the health outcomes of critically ill patients.

5 Aug 2011

Roadmap to overcome obstacles for using induced pluripotent stem cells

The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.

5 Aug 2011

Glove with special fingertip can improve wearer's sense of touch

A little vibration can be a good thing for people who need a sensitive touch. Researchers at the Georgia Institute of Technology have developed a glove with a special fingertip designed to improve the wearer's sense of touch. Applying a small vibration to the side of the fingertip improves tactile sensitivity and motor performance, according to their research results.

5 Aug 2011

Scientists develop Instant Corn Soy Blend for young children

U.S. Department of Agriculture (USDA) scientists have developed a fully cooked food-aid product called Instant Corn Soy Blend that supplements meals, particularly for young children.

5 Aug 2011

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.

4 Aug 2011

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, today announced that it has submitted an Abbreviated New Drug Application (ANDA) for chewable metformin with the U.S. Food and Drug Administration.

4 Aug 2011